FADH(.)

1910-41-4

[(2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3,4-dihydroxytetrahydro-2-furanyl]methyl (2R,3S,4S)-5-(7,8-dimethyl-2,4-dioxo-1,3,4,5-tetrahydrobenzo[g]pteridin-10(2H)-yl)-2,3,4-trihydroxypentyl dihydrogen d iphosphate (non-preferred name)

[(2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3,4-dihydroxytetrahydro-2-furanyl]methyl-(2R,3S,4S)-5-(7,8-dimethyl-2,4-dioxo-1,3,4,5-tetrahydrobenzo[g]pteridin-10(2H)-yl)-2,3,4-trihydroxypentyldihydrogendip hosphat (non-preferred name)

[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methoxy-hydroxy-phosphoryl] [(2R,3S,4S)-5-(7,8-dimethyl-2,4-dioxo-1,5-dihydrobenzo[g]pteridin-10-yl)-2,3,4-trihydroxy-pentyl] hydrogen phosphate

Dihydrogénodiphosphate de [(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytétrahydro-2-furanyl]méthyle et de (2R,3S,4S)-5-(7,8-diméthyl-2,4-dioxo-1,3,4,5-tétrahydrobenzo[g]ptéridin-10(2H)-yl)-2, 3,4-trihydroxypentyle (non-preferred name)

FADH(.)

1,5-dihydro-FAD

1,5-dihydro-P-5-ester with adenosine

1,5-Dihydro-Riboflavin 5′-(trihydrogen diphosphate) P′->5′-ester with adenosine

1208989

25342-67-0

4112594

[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy({[(2R,3S,4S)-5-{7,8-dimethyl-2,4-dioxo-1H,3H,5H-benzo[g]pteridin-10-yl}-2,3,4-trihydroxypentyl]oxy(hydroxy)phosphoryl}oxy)phosphinic acid

[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]({[(2R,3S,4S)-5-{7,8-dimethyl-2,4-dioxo-1H,2H,3H,4H,5H,10H-benzo[g]pteridin-10-yl}-2,3,4-trihydroxypentyl]oxy})phosphinic acid

Adenosine 5-(trihydrogen pyrophosphate)

adenosine 5′-(3-{D-ribo-5-[7,8-dimethyl-2,4-dioxo-1,3,4,5-tetrahydrobenzo[g]pteridin-10(2H)-yl]-2,3,4-trihydroxypentyl} dihydrogen diphosphate)

Adenosine 5′-(trihydrogen pyrophosphate), 5′-5′-ester with 5,10-dihydro-7,8-dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)alloxazine

Adenosine 5′-(trihydrogen pyrophosphate), 5′-5′-ester with 5,10-dihydro-7,8-dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)alloxazine (8CI)

Adenosine 5′-(trihydrogen pyrophosphate), 5′->5′-ester with 5,10-dihydro-7,8-dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)alloxazine

adenosine 5′-{3-[D-ribo-5-(7,8-dimethyl-2,4-dioxo-1,2,3,4,5,10-tetrahydrobenzo[g]pteridin-10-yl)-2,3,4-trihydroxypentyl] dihydrogen diphosphate}

Adenosine pyrophosphate 5′-5′-ester with 5,10-dihydro-7,8-dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)alloxazine

Adenosine pyrophosphate, 5′-5′-ester with 5,10-dihydro-7,8-dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)alloxazine

Adenosine pyrophosphate, 5′-5′-ester with 5,10-dihydro-7,8-dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)alloxazine (7CI)

Adenosine pyrophosphate, 5′->5′-ester with 5,10-dihydro-7,8-dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)alloxazine

Dihydro-FAD

DIHYDROFLAVINE-ADENINE DINUCLEOTIDE

FAD

[Wiki]

FADH

FDA

flavin adenine dinucleotide (reduced form)

flavin adenine dinucleotide (reduced)

flavin adenine dinucleotide reduced

flavin adenine dinucleotide semiquinone radical

flavin-adenine dinucleotide

Reduced flavine adenine dinucleotide

Riboflavin 5′-(trihydrogen diphosphate), 1,5-dihydro-, P′-5′-ester with adenosine

Riboflavin 5′-(trihydrogen diphosphate), 1,5-dihydro-, P′-5′-ester with adenosine (9CI)